Winslow Capital Management
DXCM icon

Winslow Capital Management’s DexCom DXCM Stock Holding History

Winslow Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,347,459
Closed -$291M – 58
2023
Q4 		$291M Buy
2,347,459
+491,942
+27% +$50.3M 1.21% 33
2023
Q3 		$173M Buy
+1,855,517
New +$209M 0.82% 41
2017
Q4 		– Sell
-3,244
Closed -$40K – 98
2017
Q3 		$40K Sell
3,244
-6,419,228
-100% -$113M ﹤0.01% 59
2017
Q2 		$117M Buy
+6,422,472
New +$119M 0.63% 60
2016
Q1 		– Sell
-13,236,856
Closed -$271M – 140
2015
Q4 		$271M Buy
13,236,856
+1,385,040
+12% +$28.8M 0.97% 49
2015
Q3 		$254M Buy
11,851,816
+1,944,816
+20% +$43.4M 0.93% 50
2015
Q2 		$198M Buy
+9,907,000
New +$174M 0.66% 62

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Winslow Capital Management's DXCM Position: Q1 2024 in Review

Winslow Capital Management sold out of DexCom (DXCM) in Q1 2024, closing a stake of 2,347,459 shares — an estimated $291M sold.

Winslow Capital Management first reported a position in DXCM in Q2 2015 and held it in 7 quarters. The position peaked at $291M in Q4 2023. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Winslow Capital Management reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Winslow Capital Management sold 2,347,459 DexCom shares in Q1 2024, an estimated $291M.
  • Winslow Capital Management first reported a position in DexCom in Q2 2015 and held it in 7 quarters.
  • Winslow Capital Management's DexCom position peaked at $291M in Q4 2023.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Winslow Capital Management's 13F filing for Q1 2024, filed 14 May 2024.